title: Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder.
abstract: There are reasons for thinking that obsessive-compulsive disorder (OCD) and drug dependence, although conventionally distinct diagnostic categories, might share important cognitive and neurobiological substrates. We tested this hypothesis directly by comparing brain functional connectivity measures between patients with OCD, stimulant dependent individuals (SDIs; many of whom were non-dependent users of other recreational drugs) and healthy volunteers. We measured functional connectivity between each possible pair of 506 brain regional functional MRI time series representing low frequency (0.03-0.06 Hz) spontaneous brain hemodynamics in healthy volunteers (N=18), patients with OCD (N=18) and SDIs (N=18). We used permutation tests to identify i) brain regions where strength of connectivity was significantly different in both patient groups compared to healthy volunteers; and ii) brain regions and connections which had significantly different functional connectivity between patient groups. We found that functional connectivity of right inferior and superior orbitofrontal cortex (OFC) was abnormally reduced in both disorders. Whether diagnosed as OCD or SDI, patients with higher scores on measures of compulsive symptom severity showed greater reductions of right orbitofrontal connectivity. Functional connections specifically between OFC and dorsal medial pre-motor and cingulate cortex were attenuated in both patient groups. However, patients with OCD demonstrated more severe and extensive reductions of functional connectivity compared to SDIs. OCD and stimulant dependence are not identical at the level of brain functional systems but they have some important abnormalities in common compared with healthy volunteers. Orbitofrontal connectivity may serve as a human brain systems biomarker for compulsivity across diagnostic categories.
authors.affiliation: Behavioral & Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
authors.forename: David
authors.initials: D
authors.lastname: Meunier
authors.forename: Karen D
authors.initials: KD
authors.lastname: Ersche
authors.forename: Kevin J
authors.initials: KJ
authors.lastname: Craig
authors.forename: Alex
authors.initials: A
authors.lastname: Fornito
authors.forename: Emilio
authors.initials: E
authors.lastname: Merlo-Pich
authors.forename: Naomi A
authors.initials: NA
authors.lastname: Fineberg
authors.forename: Shaila S
authors.initials: SS
authors.lastname: Shabbir
authors.forename: Trevor W
authors.initials: TW
authors.lastname: Robbins
authors.forename: Edward T
authors.initials: ET
authors.lastname: Bullmore
mesh_terms: D000328:Adult; D019969:Amphetamine-Related Disorders / Q000209:etiology / Q000503:physiopathology*; D001921:Brain / Q000503:physiopathology*; D000697:Central Nervous System Stimulants / Q000506:poisoning; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D009415:Nerve Net / Q000503:physiopathology*; D009771:Obsessive-Compulsive Disorder / Q000503:physiopathology*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity
chemical_list: D000697:Central Nervous System Stimulants